高胆固醇血症和炎症-合作性心血管风险因素
Antonio Gallo1, Wilfried Le Goff1, Raul D Santos2
1Lipidology and Cardiovascular Prevention Unit, Department of Nutrition, APHP, Hôpital Pitié-Salpètriêre, Sorbonne Université, INSERM UMR1166, Paris, France.
European journal of clinical investigation
|October 7, 2024
概括
降低低密度脂蛋白胆固醇 (LDLc) 对于减少动脉样硬化和心血管事件至关重要. 炎症也起着关键作用,针对炎症生物标志物可能进一步减少疾病负担.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 低血低密度脂蛋白胆固醇 (LDLc) 度降低了LDL粒子在动脉壁中的积累,减缓了动脉样硬化和延迟了动脉样硬化斑块的发展.
- 动脉样硬化斑块的发展和脆弱性受到脂质积累和炎症的影响.
- 通过随着时间的推移保持低的LDLc水平,动脉样硬化心血管疾病 (ASCVD) 的风险显著降低.
研究的目的:
- 审查与升高的LDLc.相关的炎症分子通路.
- 描述降脂疗法对炎症和脂质负担的影响.
- 为了突出LDLc与ASCVD病变发生过程中的炎症之间的相互作用.
主要方法:
- 现有文献的叙述性审查.
- 对与LDLc.升高相关的炎症分子通路的分析.
- 评估降脂方法对炎症的影响.
主要成果:
- 免疫细胞组成的变化和改变的细胞因子/化学因子释放破坏了斑块部位的炎症平衡.
- 在促进ASCVD方面,LDLc和炎症具有协同作用.
- 最近的降脂疗法显著降低了LDLc,但C反应蛋白减少可能独立于LDLc的大小.
结论:
- 鉴定临床炎症生物标志物,如白素-6,对ASCVD管理有希望.
- 针对炎症途径提供了监测和减少ASCVD负担的潜力.
- 针对脂质和炎症因素的综合方法对于有效预防ASCVD至关重要.
相关概念视频
Cholesterol: Significance and Regulation
519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
519
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
581
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
581
Atherosclerosis II: Clinical manifestations and prevention
2
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Inflammation
53.2K
Overview
53.2K


